Home     Media Contacts     Links     Sitemap     MRMC globe4.gif     MEDCOM globe4.gif     Army globe4.gif     AKO globe4.gif     CTC globe4.gif     FAQ          
HOME>>Re&Develop>>Infectious Disease>>HIV Tuesday, October 23 2018

Skip Navigation Links
Military HIV Research Program (MHRP)

The U.S. Military HIV Research Program (MHRP), centered at WRAIR, conducts research to develop an effective HIV vaccine and integrates prevention, diagnostics, treatment and monitoring as part of an international effort to protect US and Allied troops and reduce the impact of HIV infection worldwide.


In 1986, Congress initiated MHRP to protect service personnel and serve the global community by reducing the risk of HIV infection. With more than 35 million infections worldwide, HIV continues to pose a significant and persistent threat in terms of readiness and force protection, and may affect the stability and security of many nation-states. The brisk pace of deployments throughout the world requires WRAIR to develop products and capabilities with an international scope.

Building on the established infrastructure and unique capabilities of the U.S. military medical research command, WRAIR has developed a highly-targeted program, MHRP, to address these military-specific concerns including developing a globally-effective HIV vaccine, ensuring accurate HIV testing for the Army, tracking the HIV epidemic in active-duty forces and assessing risk of HIV exposure to U.S. and allied forces deployed overseas.

MHRP collaborates with two existing regional laboratories, AFRIMS and USAMRU-K, and has developed four additional international research sites in Nigeria, Tanzania, Uganda and Mozambique. Additionally, the integration of HIV prevention, care and treatment services supported by the U.S. President’s Emergency Plan for AIDS Relief has helped MHRP build strong and trusting relationships with the communities in which research is conducted, while providing an ethical framework for the conduct of HIV clinical research.

In 2009, MHRP announced results of an Army-sponsored clinical trial in Thailand, RV144, that demonstrated for the first time a modest ability to protect against HIV infection, reducing the number of infections by 31.2 percent. MHRP will continue to work in close collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) to identify and address key research areas that will help speed progress in the quest for an effective HIV vaccine.

Click to listen to COL Jerome Kim highlight the recent successes of the HIV vaccine trial called RV144.

To learn more about our Military HIV Research Program, click here  PDF Icon.

To learn more about MHRP, visit their website: globe4.gif

Last Modified Date: 09-September-2016

This Web site provides an introduction to the U.S. Army Medical Research and Materiel Command (USAMRMC) and contains official Government information. Its use is intended for members of the general public, news media and Army Medical Department beneficiaries.
Please address questions or concerns about this website to the Public Affairs Office via e-mail or by telephone at 301-319-9471.